bromodeoxyuridine has been researched along with Adrenocortical Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehrlund, A; Gustafsson, JÅ; Jonsson, P; Treuter, E; Vedin, LL; Williams, C | 1 |
1 other study(ies) available for bromodeoxyuridine and Adrenocortical Carcinoma
Article | Year |
---|---|
Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells.
Topics: Adrenal Cortex; Adrenocortical Carcinoma; beta Catenin; Blotting, Western; Bromodeoxyuridine; Carrier Proteins; Cell Line, Tumor; Colforsin; Computational Biology; Gene Expression Regulation; Gene Knockdown Techniques; Gonadal Steroid Hormones; Humans; Microarray Analysis; Polymerase Chain Reaction; RNA, Small Interfering; Steroidogenic Factor 1; Transforming Growth Factor beta; Ubiquitin-Protein Ligases; Wnt Signaling Pathway | 2012 |